Jessica Kohlschmidt

7.5k citations

50 papers · 1.1k indexed · h-index 19

Hematology top 1%
Molecular Biology
Cancer Research top 5%
Genetics top 5%
Public Health, Environmental and Occupational Health top 10%

Co-authors: Krzysztof Mrózek Clara D. Bloomfield Jonathan E. Kolitz Richard M. Stone Deedra Nicolet Bayard L. Powell Andrew J. Carroll Ann‐Kathrin Eisfeld
Topics: Acute Myeloid Leukemia Research (41 papers)Acute Lymphoblastic Leukemia research (16 papers)Chronic Myeloid Leukemia Treatments (10 papers)
Cited by: Hematology Genetics Cancer Research
Journals: Proceedings of the National Academy of Sciences Journal of Clinical OncologySHILAP Revista de lepidopterología
Partner nations: United States Germany Italy

In The Last Decade

Jessica Kohlschmidt

46 papers receiving 1.1k citations

Peers

Countries citing papers authored by Jessica Kohlschmidt

Since Specialization

Citations

This map shows the geographic impact of Jessica Kohlschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jessica Kohlschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jessica Kohlschmidt more than expected).

Fields of papers citing papers by Jessica Kohlschmidt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jessica Kohlschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jessica Kohlschmidt. The network helps show where Jessica Kohlschmidt may publish in the future.

Co-authorship network of co-authors of Jessica Kohlschmidt

This figure shows the co-authorship network connecting the top 25 collaborators of Jessica Kohlschmidt. A scholar is included among the top collaborators of Jessica Kohlschmidt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jessica Kohlschmidt. Jessica Kohlschmidt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association of social deprivation with survival in younger adult patients with AML: an Alliance study 2023 ·Blood Advances ·(unknown),Jessica Kohlschmidt,Krzysztof Mrózek,Deedra Nicolet,Alice S. Mims,James S. Blachly,Shelley Orwick,Karilyn Larkin,Christopher C. Oakes,Andrew Hantel,Andrew J. Carroll,William Blum,Bayard L. Powell,Geoffrey L. Uy,Richard M. Stone,Richard A. Larson,John C. Byrd,Electra D. Paskett,Jesse J. Plascak,Ann‐Kathrin Eisfeld	5
2	Outcome prediction by the 2022 European LeukemiaNet genetic-risk classification for adults with acute myeloid leukemia: an Alliance study 2023 ·Leukemia ·Krzysztof Mrózek,Jessica Kohlschmidt,James S. Blachly,Deedra Nicolet,Andrew J. Carroll,Kellie J. Archer,Alice S. Mims,Karilyn Larkin,Shelley Orwick,Christopher C. Oakes,Jonathan E. Kolitz,Bayard L. Powell,William Blum,Guido Marcucci,Maria R. Baer,Geoffrey L. Uy,Wendy Stock,John C. Byrd,Ann‐Kathrin Eisfeld	31
3	Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: Alliance for Clinical Trials in Oncology study 2023 ·Blood Advances ·Bhavana Bhatnagar,Jessica Kohlschmidt,Shelley Orwick,Daelynn R. Buelow,(unknown),Christopher C. Oakes,Jonathan E. Kolitz,Geoffrey L. Uy,Wendy Stock,Bayard L. Powell,Deedra Nicolet,Erin Hertlein,Krzysztof Mrózek,James S. Blachly,Ann‐Kathrin Eisfeld,Sharyn D. Baker,John C. Byrd	1
4	Effect of additional cytogenetic abnormalities on survival in arsenic trioxide-treated acute promyelocytic leukemia 2022 ·Blood Advances ·Zachary D. Epstein‐Peterson,Andriy Derkach,Susan M. Geyer,Krzysztof Mrózek,Jessica Kohlschmidt,Jae H. Park,(unknown),Eytan M. Stein,Yanming Zhang,Harry Iland,Lynda J. Campbell,Richard A. Larson,Xavier Poiré,Bayard L. Powell,Wendy Stock,Richard M. Stone,Martin S. Tallman	7
5	Impact ofIDH1andIDH2mutation detection at diagnosis and in remission in patients with AML receiving allogeneic transplantation 2022 ·Blood Advances ·Marius Bill,Madlen Jentzsch,(unknown),Jessica Kohlschmidt,Juliane Grimm,(unknown),(unknown),(unknown),(unknown),Georg‐Nikolaus Franke,Vladan Vučinić,Dietger Niederwieser,Alice S. Mims,Uwe Platzbecker,Ann‐Kathrin Eisfeld,Sebastian Schwind	22
6	A precision medicine classification for treatment of acute myeloid leukemia in older patients 2021 ·Journal of Hematology & Oncology ·Alice S. Mims,Jessica Kohlschmidt,Uma Borate,James S. Blachly,Shelley Orwick,Ann-Kathrin Eisfeld,Dimitrios Papaioannou,Deedra Nicolet,Krzysztof Mrózek,Eytan M. Stein,Bhavana Bhatnagar,Richard M. Stone,Jonathan E. Kolitz,Eunice S. Wang,Bayard L. Powell,Amy Burd,Ross L. Levine,Brian Druker,Clara D. Bloomfield,John C. Byrd	10
7	Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years 2020 ·Leukemia ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Alice S. Mims,Deedra Nicolet,Christopher J. Walker,James S. Blachly,Andrew J. Carroll,Dimitrios Papaioannou,Jonathan E. Kolitz,(unknown),Richard M. Stone,Albert de la Chapelle,John C. Byrd,Krzysztof Mrózek,Clara D. Bloomfield	56
8	Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia 2019 ·Molecular Cancer Therapeutics ·Dimitrios Papaioannou,Deedra Nicolet,Hatice Gülçin Özer,Krzysztof Mrózek,Stefano Volinia,Paolo Fadda,Andrew J. Carroll,Jessica Kohlschmidt,Jonathan E. Kolitz,Eunice S. Wang,Richard M. Stone,John C. Byrd,Ramiro Garzon,Clara D. Bloomfield	12
9	Mutations associated with a 17-gene leukemia stem cell score and the score’s prognostic relevance in the context of the European LeukemiaNet classification of acute myeloid leukemia 2019 ·Haematologica ·Marius Bill,Deedra Nicolet,Jessica Kohlschmidt,Christopher J. Walker,Krzysztof Mrózek,Ann‐Kathrin Eisfeld,Dimitrios Papaioannou,Xiaoqing Rong,(unknown),Jonathan E. Kolitz,Bayard L. Powell,Kellie J. Archer,Adrienne M. Dorrance,Andrew J. Carroll,Richard M. Stone,John C. Byrd,Ramiro Garzon,Clara D. Bloomfield	13
10	Clinical and molecular characterization of patients with acute myeloid leukemia and sole trisomies of chromosomes 4, 8, 11, 13 or 21 2019 ·Leukemia ·Bhavana Bhatnagar,Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Deedra Nicolet,Dimitrios Papaioannou,Christopher J. Walker,Shelley Orwick,James S. Blachly,Jonathan E. Kolitz,Bayard L. Powell,Andrew J. Carroll,Richard M. Stone,John C. Byrd,Clara D. Bloomfield	5
11	Prognostic and Biologic Significance of Transfer RNA-Derived Small RNAs (tsRNAs) Expression in Younger Adult Patients (Pts) with Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) 2018 ·Blood ·Marius Bill,Dario Veneziano,Jessica Kohlschmidt,Krzysztof Mrózek,Giovanni Nigita,(unknown),Deedra Nicolet,Dimitrios Papaioannou,Allison R. Walker,(unknown),Bayard L. Powell,Richard M. Stone,Geoffrey L. Uy,Jonathan E. Kolitz,Eunice S. Wang,Adrienne M. Dorrance,Carlo M. Croce,Ramiro Garzon,Clara D. Bloomfield	2
12	Neurofibromin 1 gene Mutations Are Recurrent Events in Adult Patients with Acute Myeloid Leukemia (AML), Associate with Poor Outcome and Refine the Adverse European Leukemianet (ELN) Risk Category 2017 ·Blood ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Alice S. Mims,Christopher J. Walker,James S. Blachly,Deedra Nicolet,Shelley Orwick,(unknown),Andrew J. Carroll,Bayard L. Powell,Jonathan E. Kolitz,Eunice S. Wang,Richard M. Stone,Albert de la Chapelle,John C. Byrd,Clara D. Bloomfield	0
13	Mutation Patterns Identify Adult Patients with De Novo Acute Myeloid Leukemia (AML) Aged 60 Years or Older Who Respond Favorably to Standard Chemotherapy: an Analysis of Alliance Studies 2017 ·Blood ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,James S. Blachly,Christopher J. Walker,Deedra Nicolet,Shelley Orwick,Andrew J. Carroll,Richard M. Stone,Eunice S. Wang,Jonathan E. Kolitz,Bayard L. Powell,Albert de la Chapelle,John C. Byrd,Clara D. Bloomfield	0
14	No evidence for microsatellite instability in acute myeloid leukemia 2017 ·Leukemia ·Christopher J. Walker,(unknown),(unknown),(unknown),Jessica Kohlschmidt,Krzysztof Mrózek,Andrew J. Carroll,Jonathan E. Kolitz,Bayard L. Powell,Eunice S. Wang,Richard M. Stone,Ralf Bundschuh,Albert de la Chapelle,Clara D. Bloomfield	9
15	Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality 2016 ·Cancer Research ·Ann‐Kathrin Eisfeld,Jessica Kohlschmidt,Krzysztof Mrózek,Stefano Volinia,James S. Blachly,Deedra Nicolet,Christopher C. Oakes,(unknown),Shelley Orwick,Andrew J. Carroll,Richard M. Stone,John C. Byrd,Albert de la Chapelle,Clara D. Bloomfield	16
16	Chromosome abnormalities at onset of complete remission are associated with worse outcome in patients with acute myeloid leukemia and an abnormal karyotype at diagnosis: CALGB 8461 (Alliance) 2016 ·Haematologica ·Christian Niederwieser,Deedra Nicolet,Andrew J. Carroll,Jonathan E. Kolitz,Bayard L. Powell,Jessica Kohlschmidt,R. M. Stone,John C. Byrd,Krzysztof Mrózek,C. D. Bloomfield	13
17	Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503) 2016 ·Leukemia ·William Blum,Ben L. Sanford,Rebecca B. Klisovic,Daniel J. DeAngelo,Geoffrey L. Uy,Bayard L. Powell,Wendy Stock,Maria R. Baer,Jonathan E. Kolitz,Eunice S. Wang,Eva Hoke,Krzysztof Mrózek,Jessica Kohlschmidt,Clara D. Bloomfield,Susan Geyer,Guido Marcucci,Richard M. Stone,Richard A. Larson	60
18	New recurrent balanced translocations in acute myeloid leukemia and myelodysplastic syndromes: Cancer and leukemia group B 8461 2012 ·Genes Chromosomes and Cancer ·Alison Walker,Krzysztof Mrózek,Jessica Kohlschmidt,Kathleen W. Rao,Mark J. Pettenati,(unknown),Guido Marcucci,Andrew J. Carroll,Clara D. Bloomfield	6
19	Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study 2011 ·Haematologica ·Heiko Becker,Kati Maharry,Michael D. Radmacher,Krzysztof Mrózek,Klaus H. Metzeler,Susan P. Whitman,Sebastian Schwind,Jessica Kohlschmidt,Yaran Wu,Bayard L. Powell,Thomas H. Carter,Jonathan E. Kolitz,Meir Wetzler,A J Carroll,Maria R. Baer,Joseph O. Moore,M. A. Caligiuri,Richard A. Larson,Guido Marcucci,C. D. Bloomfield	18
20	RANKED SET SAMPLING: A LOOK AT ALLOCATION ISSUES AND MISSING DATA COMPLICATIONS 2009 ·OhioLink ETD Center (Ohio Library and Information Network) ·Jessica Kohlschmidt	1

About Jessica Kohlschmidt

Jessica Kohlschmidt is a scholar working on Hematology, Genetics and Cancer Research, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (41 papers), Acute Lymphoblastic Leukemia research (16 papers) and Chronic Myeloid Leukemia Treatments (10 papers). The work is most often cited by research in Hematology (765 citations), Genetics (239 citations) and Cancer Research (313 citations). Jessica Kohlschmidt has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include Krzysztof Mrózek, Clara D. Bloomfield, Jonathan E. Kolitz, Richard M. Stone, Deedra Nicolet, Bayard L. Powell, Andrew J. Carroll, Ann‐Kathrin Eisfeld, John C. Byrd and James S. Blachly. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact